HMGA2 overexpression in polycythemia vera with t(12;21)(q14;q22)

被引:11
作者
Aliano, Stefania
Cirmena, Gabriella
Garuti, Anna
Fugazza, Giuseppina
Bruzzone, Roberto
Rocco, Ilaria
Malacarne, Michela
Ballestrero, Alberto
Sessarego, Mario
机构
[1] Univ Genoa, Dept Internal Med, Lab Cytogenet, I-16132 Genoa, Italy
[2] EO Galliera Hosp, Lab Human Genet, Genoa, Italy
关键词
D O I
10.1016/j.cancergencyto.2007.05.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chromosomal translocations involving the 12q14 band are rarely detected in hematological disorders, and are usually correlated with HMGA2 gene expression. HMGA2 is highly expressed during embryonic cell growth and differentiation, and regulates transcription and chromatin organization, but is rarely detectable in adult tissues. We describe a case of polycythemia vera with a t(12;21)(q14;q22). The 12q14 breakpoint was characterized by fluorescence in situ hybridization analysis using the bacterial artificial chromosome RP11-366L20 containing 3' sequences of the HMGA2 gene. Qualitative and quantitative polymerase chain reaction showed the presence of high levels of HMGA2 gene expression, which were temporarily reduced with hydroxyurea, therapy. The present case confirms that involvement of the 12q14 band may be associated with HMGA2 overexpression in chronic Philadelphia chromosome-negative myeloproliferative disease, regardless of the partner chromosome involved in the translocation. Such overexpression may contribute to the pathogenesis of the disease, which otherwise of itself shows a favorable and stable course. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:115 / 119
页数:5
相关论文
共 21 条
[1]   An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue [J].
Abe, N ;
Watanabe, T ;
Suzuki, Y ;
Matsumoto, N ;
Masaki, T ;
Mori, T ;
Sugiyama, M ;
Chiappetta, G ;
Fusco, A ;
Atomi, Y .
BRITISH JOURNAL OF CANCER, 2003, 89 (11) :2104-2109
[2]   Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia [J].
Andrieux, J ;
Demory, JL ;
Dupriez, B ;
Quief, S ;
Plantier, I ;
Roumier, C ;
Bauters, F ;
Laï, JL ;
Kerckaert, JP .
GENES CHROMOSOMES & CANCER, 2004, 39 (01) :82-87
[3]  
Ballestrero A, 2001, CANCER-AM CANCER SOC, V92, P2030, DOI 10.1002/1097-0142(20011015)92:8<2030::AID-CNCR1541>3.0.CO
[4]  
2-G
[5]   Construction and analysis of cells lacking the HMGA gene family [J].
Beitzel, B ;
Bushman, F .
NUCLEIC ACIDS RESEARCH, 2003, 31 (17) :5025-5032
[6]   High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity [J].
Borrmann, L ;
Schwanbeck, R ;
Heyduk, T ;
Seebeck, B ;
Rogalla, P ;
Bullerdiek, J ;
Wisniewski, JR .
NUCLEIC ACIDS RESEARCH, 2003, 31 (23) :6841-6851
[7]   The expression of HMGA genes is regulated by their 3′UTR [J].
Borrmann, L ;
Wilkening, S ;
Bullerdiek, J .
ONCOGENE, 2001, 20 (33) :4537-4541
[8]   Mechanisms of disease: The myeloproliferative disorders [J].
Campbell, Peter J. ;
Green, Anthony R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2452-2466
[9]   HMGA molecules in neuroblastic tumors [J].
Cerignoli, F ;
Ambrosi, C ;
Mellone, M ;
Massimi, I ;
Di Marcotullio, L ;
Gulino, A ;
Giannini, G .
SIGNAL TRANSDUCTION AND COMMUNICATION IN CANCER CELLS, 2004, 1028 :122-132
[10]   Transactivation functions of the tumor-specific HMGA2/LPP fusion protein are augmented by wild-type HMGA2 [J].
Crombez, KRMO ;
Vanoirbeek, EMR ;
Van de Ven, WJM ;
Petit, MMR .
MOLECULAR CANCER RESEARCH, 2005, 3 (02) :63-70